Taoyuan City, Taiwan

Pan-Hsien Kuo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fbd Biologics Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pan-Hsien Kuo. Retrieved from https://idiyas.com/inventor/pan-hsien-kuo-zrbcbusf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pan-Hsien Kuo: Innovator in Protein Complexes

Introduction

Pan-Hsien Kuo is a notable inventor based in Taoyuan City, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of protein complexes that have potential therapeutic applications.

Latest Patents

Kuo holds a patent for a "CD47/PD-L1-Targeting Protein Complex and Methods of Use Thereof." This innovative work focuses on targeting specific proteins that play a crucial role in immune response, which could lead to advancements in cancer treatment.

Career Highlights

Kuo is currently employed at FBD Biologics Limited, where he continues to push the boundaries of biological research. His work is characterized by a commitment to developing novel solutions that address critical health challenges.

Collaborations

Kuo collaborates with esteemed colleagues, including Jiin-Tarng Wang and Han-Fang Teng, to enhance the impact of his research and innovations.

Conclusion

Pan-Hsien Kuo's contributions to the field of biotechnology, particularly through his patent and collaborative efforts, highlight his role as a key innovator in the development of therapeutic protein complexes. His work promises to advance medical science and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…